JP2018530578A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018530578A5 JP2018530578A5 JP2018518950A JP2018518950A JP2018530578A5 JP 2018530578 A5 JP2018530578 A5 JP 2018530578A5 JP 2018518950 A JP2018518950 A JP 2018518950A JP 2018518950 A JP2018518950 A JP 2018518950A JP 2018530578 A5 JP2018530578 A5 JP 2018530578A5
- Authority
- JP
- Japan
- Prior art keywords
- linezolid
- administered
- pharmaceutically acceptable
- composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- TYZROVQLWOKYKF-ZDUSSCGKSA-N linezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCOCC1 TYZROVQLWOKYKF-ZDUSSCGKSA-N 0.000 claims description 25
- 229960003907 linezolid Drugs 0.000 claims description 25
- 239000008194 pharmaceutical composition Substances 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 7
- 239000003937 drug carrier Substances 0.000 claims description 6
- 229960005206 pyrazinamide Drugs 0.000 claims description 6
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 claims description 6
- 229960000508 bedaquiline Drugs 0.000 claims description 5
- QUIJNHUBAXPXFS-XLJNKUFUSA-N bedaquiline Chemical compound C1([C@H](C2=CC3=CC(Br)=CC=C3N=C2OC)[C@@](O)(CCN(C)C)C=2C3=CC=CC=C3C=CC=2)=CC=CC=C1 QUIJNHUBAXPXFS-XLJNKUFUSA-N 0.000 claims description 5
- 238000011282 treatment Methods 0.000 claims description 4
- 201000008827 tuberculosis Diseases 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims 12
- 229940020914 linezolid 600 mg Drugs 0.000 claims 1
- 238000000034 method Methods 0.000 description 12
- 238000011269 treatment regimen Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562241280P | 2015-10-14 | 2015-10-14 | |
| US62/241,280 | 2015-10-14 | ||
| PCT/US2016/055414 WO2017066053A1 (en) | 2015-10-14 | 2016-10-05 | Combination antibacterial composition and short-course antibacterial regimen |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020196684A Division JP7221922B2 (ja) | 2015-10-14 | 2020-11-27 | 組み合せ抗細菌組成物および短期抗細菌レジメン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018530578A JP2018530578A (ja) | 2018-10-18 |
| JP2018530578A5 true JP2018530578A5 (enExample) | 2019-10-31 |
| JP6845233B2 JP6845233B2 (ja) | 2021-03-17 |
Family
ID=58518568
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018518950A Active JP6845233B2 (ja) | 2015-10-14 | 2016-10-05 | 組み合せ抗細菌組成物および短期抗細菌レジメン |
| JP2020196684A Active JP7221922B2 (ja) | 2015-10-14 | 2020-11-27 | 組み合せ抗細菌組成物および短期抗細菌レジメン |
| JP2022063917A Pending JP2022082753A (ja) | 2015-10-14 | 2022-04-07 | 組み合せ抗細菌組成物および短期抗細菌レジメン |
| JP2024034841A Pending JP2024053045A (ja) | 2015-10-14 | 2024-03-07 | 組み合せ抗細菌組成物および短期抗細菌レジメン |
| JP2024151159A Pending JP2024167369A (ja) | 2015-10-14 | 2024-09-03 | 組み合せ抗細菌組成物および短期抗細菌レジメン |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020196684A Active JP7221922B2 (ja) | 2015-10-14 | 2020-11-27 | 組み合せ抗細菌組成物および短期抗細菌レジメン |
| JP2022063917A Pending JP2022082753A (ja) | 2015-10-14 | 2022-04-07 | 組み合せ抗細菌組成物および短期抗細菌レジメン |
| JP2024034841A Pending JP2024053045A (ja) | 2015-10-14 | 2024-03-07 | 組み合せ抗細菌組成物および短期抗細菌レジメン |
| JP2024151159A Pending JP2024167369A (ja) | 2015-10-14 | 2024-09-03 | 組み合せ抗細菌組成物および短期抗細菌レジメン |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20180280401A1 (enExample) |
| EP (2) | EP3362068B1 (enExample) |
| JP (5) | JP6845233B2 (enExample) |
| KR (2) | KR102706436B1 (enExample) |
| CN (2) | CN108495631A (enExample) |
| AU (3) | AU2016338637A1 (enExample) |
| BR (1) | BR112018007625A2 (enExample) |
| CA (1) | CA3001309C (enExample) |
| EA (1) | EA201890614A1 (enExample) |
| ES (1) | ES2972618T3 (enExample) |
| HK (1) | HK1254620A1 (enExample) |
| HR (1) | HRP20240309T1 (enExample) |
| PL (1) | PL3362068T3 (enExample) |
| WO (1) | WO2017066053A1 (enExample) |
| ZA (1) | ZA201802236B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102706436B1 (ko) * | 2015-10-14 | 2024-09-12 | 더 글로벌 얼라이언스 포 티비 드러그 디벨롭먼트, 잉크. | 조합 항박테리아 조성물 및 단기 항박테리아 요법 |
| US11141384B2 (en) | 2017-07-14 | 2021-10-12 | Janssen Pharmaceutica Nv | Long-acting formulations |
| CN109387594B (zh) * | 2017-08-08 | 2021-01-19 | 武汉武药科技有限公司 | 一种分离和分析贝达喹啉光学异构体的方法 |
| KR102782650B1 (ko) * | 2019-07-19 | 2025-03-19 | 더 글로벌 얼라이언스 포 티비 드러그 디벨롭먼트, 잉크. | 프레토마니드 조성물 |
| EP4164645A4 (en) * | 2020-06-15 | 2024-07-10 | The Global Alliance for TB Drug Development, Inc. | COMBINED ANTIBACTERIAL COMPOSITION AND ANTIBACTERIAL THERAPY METHOD |
| WO2021257461A1 (en) * | 2020-06-15 | 2021-12-23 | Mylan Laboratories Limited | Combination antibacterial composition and method for antibacterial therapy |
| GB202009684D0 (en) * | 2020-06-26 | 2020-08-12 | Viiv Healthcare Co | Formulations |
| AU2022214530B2 (en) * | 2021-02-01 | 2025-12-11 | The Global Alliance For Tb Drug Development, Inc. | Pretomanid amorphous form |
| CN121604963A (zh) | 2023-07-18 | 2026-03-03 | 詹森药业有限公司 | 包含贝达喹啉、普托马尼或德拉马尼的至少三种抗生素与细胞色素bc1抑制剂的组合产品及其在治疗分枝杆菌感染中的用途 |
| CN117137918A (zh) * | 2023-09-28 | 2023-12-01 | 深圳国家感染性疾病临床医学研究中心 | 一种药物组合物及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7889101B2 (en) * | 2008-04-14 | 2011-02-15 | Alpine Electronics, Inc | Method and apparatus for generating location based reminder message for navigation system |
| BRPI0918802A2 (pt) * | 2008-09-03 | 2019-09-17 | Pfizer | uso de (s)-n-[[3-[3-fluoro-4-(4-tiomorfolinil)fenil]-2-oxo-5-oxazolidinil] metil] acetamida e composição farmacêutica |
| WO2011139832A2 (en) * | 2010-04-28 | 2011-11-10 | Rib-X Pharmaceuticals, Inc. | Method for treating mycobacterial infections |
| KR102706436B1 (ko) * | 2015-10-14 | 2024-09-12 | 더 글로벌 얼라이언스 포 티비 드러그 디벨롭먼트, 잉크. | 조합 항박테리아 조성물 및 단기 항박테리아 요법 |
-
2016
- 2016-10-05 KR KR1020187013661A patent/KR102706436B1/ko active Active
- 2016-10-05 PL PL16855973.0T patent/PL3362068T3/pl unknown
- 2016-10-05 CN CN201680073150.2A patent/CN108495631A/zh active Pending
- 2016-10-05 ES ES16855973T patent/ES2972618T3/es active Active
- 2016-10-05 US US15/765,310 patent/US20180280401A1/en active Pending
- 2016-10-05 CA CA3001309A patent/CA3001309C/en active Active
- 2016-10-05 EA EA201890614A patent/EA201890614A1/ru unknown
- 2016-10-05 CN CN202210425060.2A patent/CN114796231A/zh active Pending
- 2016-10-05 EP EP16855973.0A patent/EP3362068B1/en active Active
- 2016-10-05 HK HK18113586.3A patent/HK1254620A1/zh unknown
- 2016-10-05 AU AU2016338637A patent/AU2016338637A1/en not_active Abandoned
- 2016-10-05 JP JP2018518950A patent/JP6845233B2/ja active Active
- 2016-10-05 BR BR112018007625A patent/BR112018007625A2/pt not_active Application Discontinuation
- 2016-10-05 HR HRP20240309TT patent/HRP20240309T1/hr unknown
- 2016-10-05 EP EP23214018.6A patent/EP4324824A3/en active Pending
- 2016-10-05 KR KR1020247030236A patent/KR20240137128A/ko not_active Ceased
- 2016-10-05 WO PCT/US2016/055414 patent/WO2017066053A1/en not_active Ceased
-
2018
- 2018-04-05 ZA ZA2018/02236A patent/ZA201802236B/en unknown
-
2020
- 2020-04-09 US US16/843,946 patent/US20200237770A1/en not_active Abandoned
- 2020-11-27 JP JP2020196684A patent/JP7221922B2/ja active Active
-
2021
- 2021-10-28 AU AU2021258039A patent/AU2021258039B2/en active Active
-
2022
- 2022-04-07 JP JP2022063917A patent/JP2022082753A/ja active Pending
-
2023
- 2023-09-06 US US18/242,560 patent/US20230414625A1/en active Pending
-
2024
- 2024-03-07 JP JP2024034841A patent/JP2024053045A/ja active Pending
- 2024-05-07 AU AU2024203012A patent/AU2024203012B2/en active Active
- 2024-09-03 JP JP2024151159A patent/JP2024167369A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018530578A5 (enExample) | ||
| JP2012193216A5 (enExample) | ||
| JP2016185995A5 (enExample) | ||
| JP2016515628A5 (enExample) | ||
| JP2018506550A5 (enExample) | ||
| JP2019536805A5 (enExample) | ||
| JP2019516733A5 (enExample) | ||
| JP2016530280A5 (enExample) | ||
| JP2018507243A5 (enExample) | ||
| JP2017533220A5 (enExample) | ||
| JP2017531033A5 (enExample) | ||
| JP2016147915A5 (enExample) | ||
| JP2017160178A5 (enExample) | ||
| JP2019530713A5 (enExample) | ||
| RU2017134443A (ru) | Способ лечения с применением традипитанта | |
| HRP20240309T1 (hr) | Kombinirani antibakterijski pripravak i kratkotrajni antibakterijski režim, koji uključuje linezolid, bedakvilin i pretomanid | |
| JP2017503014A5 (enExample) | ||
| JP2019530706A5 (enExample) | ||
| JP2018521007A5 (enExample) | ||
| JP2017512194A5 (enExample) | ||
| JP2021509395A5 (enExample) | ||
| JP2018524306A5 (enExample) | ||
| JP2014507475A5 (enExample) | ||
| JP2017537927A5 (enExample) | ||
| JP2019534251A5 (enExample) |